نتائج البحث - Pascal Foucher

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    Antibiotic Use Does Not Appear to Influence Response to Nivolumab

    Antibiotic Use Does Not Appear to Influence Response to Nivolumab حسب Courèche Kaderbhaï, Corentin Richard, Jean David Fumet, Anne Aarnink, Pascal Foucher, Bruno Coudert, Laure Favier, Aurélie Lagrange, Emeric Limagne, Romain Boidot, François Ghiringhelli

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Drugs that may injure the respiratory system

    Drugs that may injure the respiratory system حسب Pascal Foucher, M Biour, J. P. Blayac, P. Godard, C Sgro, M Kuhn, JM Vergnon, D. Vervloët, Pierre Pfitzenmeyer, Michel Ollagnier, C Mayaud, P. Camus

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes

    Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to elimina... حسب S. Audia, Alexandra Nicolas, Dominique Cathelin, Nicolas Larmonier, Christophe Ferrand, Pascal Foucher, A Fanton, Emilie Bergoin, Marc Maynadié, Laurent Arnould, Andrew Bateman, B. Lorcerie, Éric Solary, Bruno Chauffert, Bernard Bonnotte

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)

    Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo) حسب Balázs Halmos, Eng-Huat Tan, Ross A. Soo, Jacques Cadranel, Min Ki Lee, Pascal Foucher, Te‐Chun Hsia, Maximilian J. Hochmair, Frank Griesinger, Toyoaki Hida, Edward Kim, Barbara Melosky, Angela Märten, Enric Carcereny

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

    BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers حسب S. Couraud, Pierre-Jean Souquet, Christophe Paris, Pascal Dô, H. Doubre, Éric Pichon, A. Dixmier, Isabelle Monnet, B. Étienne-Mastroïanni, Michel Vincent, Jean Trédaniel, Marielle Perrichon, Pascal Foucher, Bruno Coudert, Denis Moro‐Sibilot, Éric Dansin, Stéphanie Labonne, Pascale Missy, Franck Morin, Hélène Blanché, Gérard Zalcman

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project—Part 2)

    Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib i... حسب Jacques Cadranel, Audrey Mauguen, M Faller, Gérard Zalcman, Marie‐Pierre Buisine, Virginie Westeel, Élisabeth Longchampt, Marie Wislez, Bruno Coudert, Catherine Daniel, Bruno Chetaille, Stefan Michiels, Hélène Blons, Jérôme Solassol, Florence de Fraipont, Pascal Foucher, T. Urban, Ludovic Lacroix, Virginie Poulot, Élisabeth Quoix, Martine Antoine, G Danton, Franck Morin, C. Chouaïd, Jean‐Pierre Pignon

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002

    Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002 حسب S. Couraud, Felipe Vaca‐Paniagua, Stéphanie Villar, Javier Oliver, Tibor Schuster, Hélène Blanché, Nicolas Girard, Jean Trédaniel, Laurent Guilleminault, Radj Gervais, Nathalie Prim, Michel Vincent, J. Margery, Sébastien Larivé, Pascal Foucher, Bernard Duvert, Maxime Vallée, Florence Le Calvez‐Kelm, James McKay, Pascale Missy, Franck Morin, Gérard Zalcman, Magali Olivier, Pierre-Jean Souquet

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Implementation and use of whole exome sequencing for metastatic solid cancer

    Implementation and use of whole exome sequencing for metastatic solid cancer حسب Manon Réda, Corentin Richard, Aurélie Bertaut, Julie Niogret, Thomas Collot, Jean David Fumet, Julie Blanc, Caroline Truntzer, Isabelle Desmoulins, Sylvain Ladoire, Audrey Hennequin, Laure Favier, Leila Bengrine, Julie Vincent, Alice Hervieu, Jean-Florian Guion Dusserre, Côme Lepage, Pascal Foucher, Christophe Borg, Juliette Albuisson, Laurent Arnould, Sophie Nambot, Laurence Faivre, Romain Boidot, François Ghiringhelli

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

    Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy حسب Jean-David Fumet, Corentin Richard, Fanny Ledys, Quentin Klopfenstein, Philippe Joubert, Bertrand Routy, Caroline Truntzer, Andréanne Gagné, Marc-André Hamel, Camila Figueiredo Guimaraes, Bruno Coudert, Laurent Arnould, Laure Favier, Aurélie Lagrange, Sylvain Ladoire, Pierre Saintigny, Sandra Ortiz‐Cuaran, M. Pérol, Pascal Foucher, Paul Hofman, Marius Ilié, Sandy Chevrier, Romain Boidot, Valentin Dérangère, François Ghiringhelli

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

    Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial حسب Jean-Louis Pujol, A. Lavolé, Élisabeth Quoix, Olivier Molinier, P.-J. Souquet, Fabrice Barlési, H. Le Caer, Denis Moro‐Sibilot, P. Fournel, J.P. Oster, Patrick Chatellain, P. Barre, G. Jeannin, Pierre Mourlanette, Marc Derollez, Dominique Herman, Aldo Renault, C. Dayen, Pierre‐Jean Lamy, Alexandra Langlais, Franck Morin, Gérard Zalcman, Virginie Westeel, M. Poudenx, Julien Mazières, Y. Martinet, J-P. Gury, Nathalie Baize, Patrick Dumont, F. Vaylet, Pascal Foucher, Jérôme Dauba, Jean Trédaniel, H. Laize, L. Petit, D. Coëtmeur, H. Doubre, Éric Pichon, S. Schneider, F. Goutorbe, R. Gervais, M. Zaegel, S. Dehette, Bruno Coudert, J-P. Duhamel, A. Dixmier, Luc Thiberville, Philippe Deguiral, H. Monnot, P. Romand, H. Berard, C. Raspaud

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: